{"slug":"selank-glp-1","verification":{"valid":true,"entries":2,"head":"2adc0e4bdeb93b95c33fff7a6bcd29ad3a300a182fc0a268e83e0e5f90d8e6d2"},"energy":{"passes":2,"tokens_in":28235,"tokens_out":3047,"tokens_total":31282,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"2adc0e4bdeb93b95c33fff7a6bcd29ad3a300a182fc0a268e83e0e5f90d8e6d2"},"provenance":[{"ts":"2026-06-30T00:43:46.384Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Selank for Glp 1\nSlug: selank-glp-1\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"selank\",\"name\":\"Selank\"}],\"drugs_in_scope\":[\"glp1-agonists\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"selank\",\"name\":\"Selank\",\"section_title\":\"Why Selank might help you\",\"layer\":\"anxiety / neurochemistry\",\"steps\":[\"**What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\",\"**What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\",\"**Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n2. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n3. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"glp1-agonists\",\"name\":\"GLP-1 agonists (class)\",\"section_title\":\"Why GLP-1 agonists (class) matters for you\",\"steps\":[\"**Drug:** GLP-1 agonists (class)\",\"**Wh","response":"{\n  \"slug\": \"selank-glp-1\",\n  \"title\": \"Selank and GLP-1 Agonists: Evidence on Anxiety and Neurochemistry Layers\",\n  \"body\": \"## What's breaking down\\n\\nNo single degenerative condition is defined by the slug, but the cross points to neurochemical stress layers that can accompany GLP-1 agonist use. Chronic metabolic shifts, altered gut signaling, or lifestyle changes from these drugs may sustain non-restorative arousal states. Anxiety pathways and neurotransmitter balance sit at one layer where repair mechanisms are studied separately from the metabolic actions of the drug class.\\n\\n## Why Selank might help you\\n\\n1. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n2. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n3. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\\n\\n## Why GLP-1 agonists (class) matters for you\\n\\n1. **Drug:** GLP-1 agonists (class)\\n2. **What it does:** Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.\\n3. **Therefore for you:** This drug class supports metabolism through glucose control and appetite effects. It does not directly address neurochemistry or anxiety layers; any calming benefit would come indirectly from metabolic improvements rather than targeted repair of stress chemistry.\\n\\n## How these fit together\\n\\nSingle-compound focus — Selank targets the anxiety / neurochemistry layer. GLP-1 agonists handle metabolic support. The two address distinct degeneration layers without overlap in primary studied pathways.\\n\\n## What the evidence actually shows\\n\\nHuman data on Selank consists of small Russian trials comparing it to benzodiazepines such as medazepam in patients with generalized anxiety disorder and neurasthenia. One trial with 62 participants found similar anxiolytic effects plus additi","tokens_in":28235,"tokens_out":3047,"cost":0,"prev":"genesis","hash":"2c2edc137ecf652c8e1636f29992b80ca3d00656e695de1f6f847819e4f638ed"},{"ts":"2026-07-17T02:41:37.238Z","model":"owner","action":"voxel_divide","prompt":"","input":"selank-glp-1","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2c2edc137ecf652c8e1636f29992b80ca3d00656e695de1f6f847819e4f638ed","hash":"2adc0e4bdeb93b95c33fff7a6bcd29ad3a300a182fc0a268e83e0e5f90d8e6d2"}]}